- 4x24 Member Coverage
SAS has secured a potential $49.9M blanket purchase agreement to provide the Food and Drug Administration access to the company’s cloud-based artificial intelligence, analytic and data management platform. The FDA’s Center for Drug Evaluation and Research will implement the SAS Viya platform in efforts to update drug regulatory processes...